Related Experiment Videos
An atypical presentation for primary sclerosing cholangitis
V A Luketic1, D A Gomez, A J Sanyal
1Hepatology Section, Medical College of Virginia, Virginia Commonwealth University, Richmond 23298, USA.
Digestive Diseases and Sciences
|November 19, 1997
Summary
This study identifies a subset of patients initially diagnosed with autoimmune hepatitis who actually have primary sclerosing cholangitis. Early cholangiography is recommended for autoimmune hepatitis patients with partial steroid response and elevated alkaline phosphatase.
Area of Science:
- Hepatology
- Gastroenterology
- Autoimmune Diseases
Background:
- Differentiating autoimmune hepatitis (AIH) from primary sclerosing cholangitis (PSC) can be challenging.
- Atypical PSC cases may initially present with features overlapping AIH.
Observation:
- Patients with atypical PSC (Group I) initially diagnosed with AIH showed distinct clinical and biochemical patterns.
- While AST levels were similar in Group I and AIH (Group III), ALP levels were disproportionately elevated in Group I.
- Histological findings like triaditis and piecemeal necrosis were common across AIH and atypical PSC groups.
Findings:
- Response to corticosteroids differed significantly: AIH groups (III and IV) normalized AST, whereas Group I showed only partial AST improvement.
- The development of an alkaline phosphatase (ALP)-predominant pattern was a key indicator in Group I.
- Cholangiography confirmed PSC in all Group I patients, highlighting its diagnostic utility.
Implications:
- Early cholangiography is crucial for patients with suspected AIH who exhibit partial corticosteroid response and an ALP-predominant pattern.
- This diagnostic approach can prevent misdiagnosis and ensure timely treatment for atypical PSC.
- Improved differentiation between AIH and PSC can lead to more effective patient management strategies.